Verified RAC-US dumps Q&As 100% Pass in First Attempt Guaranteed Updated Dump from PrepAwayPDF [Q21-Q37]

NO.21 What are the MOST important elements that global regulatory agencies want to know before approving a new product for sale in their countries?

NO.22 SOPs for preventive and corrective actions MUST include the procedure to eliminate which of the following?

NO.23 Which of the following situations does NOT require rapid communication to regulatory authorities?

NO.24 A company is preparing the submission package for a drug to be registered in international markets. When preparing the legal documentation, which document MUST comply with the
WHO recommendations?

NO.25 In a distribution contract for high-risk medical devices, which of the following regulatory requirements is the MOST important for the distributor?

NO.26 Which of the following is the MOST desirable timing and approach for a regulatory affairs professional who wants to provide feedback on proposed new regulations?

NO.27 During several monitoring visits, a clinical trial monitor identifies serious and repeated noncompliance on the part of the PI. What action should the sponsor take?

NO.28 The regulatory authority contacts the regulatory affairs professional regarding a complaint about a drug produced by the company. A consumer reported to the regulatory authority that the tablets have a slightly different color and break easily.
Which of the following actions should the regulatory affairs professional take?

NO.29 Which of the following is MOST appropriate for the purpose of lot release of biologics?

NO.30 The intermediate manufacturing process was changed during development of a pharmaceutical. The change may impact the API specification. Which functional area is responsible for the final approval of the change?

NO.31 Which question is pertinent to demonstrate a new pharmaceutical’s effectiveness during evaluation by a reimbursement agency?

NO.32 According to the GHTF IVD guidance, which of the following is the CORRECT classification for a blood glucose self-testing kit?

NO.33 The API used for an approved drug product conforms to international monograph specifications and local pharmacopeia; however, the international monograph specifications of the API will be changing soon. Which is the most appropriate action for the regulatory affairs professional to take FIRST?

NO.34 A company receives multiple complaints regarding the text included on a recently launched product’s label. What action should the regulatory affairs professional take FIRST?

NO.35 A company is developing a new line of products in an area that is new to the company.
What is the BEST approach?

NO.36 According to WHO, what are the temperature and humidity conditions for a Zone IVb long- term stability study?

NO.37 A regulatory authority announces an inspection of a regulatory affairs professional’s facility during a holiday season when most of the staff Is not available. What is the MOST practical approach to this dilemma?